Article Details
Retrieved on: 2025-01-19 17:07:19
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the impending entry of pioneering anti-obesity drugs like Wegovy, Ozempic, and tirzepatide into India, addressing the nation's public health crisis related to obesity. The drug's connection to peptide hormones and their impact on conditions like diabetes is highlighted through pharmaceutical initiatives from companies like Novo Nordisk and Eli Lilly preparing competitive strategies for the Indian market.
Article found on: www.financialexpress.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here